Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension

Journal of Heart and Lung Transplantation

Volumn 29, Issue 2, 2010, Pages 201-208

  Nair, Pradeep K ^a   Kormos, Robert L ^a   Teuteberg, Jeffrey J ^a   Mathier, Michael A ^a   Bermudez, Christian A ^a   Toyoda, Yoshiya ^a   Dew, Mary Amanda ^a   Simon, Marc A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PA 15260   (United States)

Author keywords

adult; heart failure; heart assist devices; outcomes; pulmonary hypertension; transplantation

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL RATE;

ADULT; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 74949113026     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.09.013     Document Type: Article

References (29)

1. Massad M.G. Surgical options for the management of congestive heart failure. Cardiology 101 (2004) 5-6
2. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Keck B.M., and Hertz M.I. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 796-803
3. Constanzo M.R., Augustine S., Bouge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
4. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 (2006) 1024-1042
5. Kirklin J.K., Naftel D.C., Kirklin J.W., Blackstone E.H., White-Williams C., and Bourge R.C. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7 (1988) 331-336
6. Campana C., Gavazzi A., Marioni R., et al. Right ventricular failure after heart transplantation: relationship with preoperative hemodynamic parameters. Transpl Int 5 (1992) S221-S223
7. Abramson S.V., Burke J.F., Kelly J.J., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116 (1992) 888-895
8. Mancini D.M. Pulmonary factors limiting exercise capacity in patients with heart failure. Prog Cardiovasc Dis 38 (1995) 347-370
9. Klotz S., Wenzelburger F., Stypmann J., et al. Reversible pulmonary hypertension in heart transplant candidates: To transplant or not to transplant. Ann Thorac Surg 82 (2003) 1770-1773
10. Costard-Jackle A., and Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19 (1992) 48-54
11. Espinoza C., Manito N., Roca J., et al. Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortality. Transplant Proc 31 (1999) 2503-2504
12. Tenderich G., Koerner M.M., Stuettgen B., et al. Does pre-existing elevated pulmonary vascular resistance (transpulmonary gradient > 15 mmHg or > 5 wood) predict early and long-term results after orthotopic heart transplantation?. Transplant Proc 30 (1998) 1130-1131
13. Delgado J.F., Gomez-Sanchez M.A., Saenz de la Calzada C., et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant 20 (2001) 942-948
14. McCarthy P.M., Smedira N.O., Vargo R.L., et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 115 (1998) 904-912
15. Oz M.C., Argenziano M., Catanese K.A., et al. Bridge experience with long-term implantable left ventricular assist devices. Circulation 95 (1997) 1844-1852
16. Gallagher R.C., Kormos R.L., Gasior T., Murali S., Griffith B.P., and Hardesty R.L. Univentricular support results in reduction of pulmonary resistance and improved right ventricular function. ASAIO Trans 37 (1991) M287-M288
17. Zimpfer D., Zrunek P., Roethy W., et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 133 (2007) 689-695
18. Salzberg S.P., Lachat M.L., von Harbou K., Zund G., and Turina M. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27 (2005) 222-225
19. Etz C.D., Welp H.A., Tjan T.D., et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 83 (2007) 1697-1706
20. Martin J., Siegenthaler M.P., Friesewinkel O., et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 25 (2004) 971-977
21. Wilson S.R., Mudge G.H., Stewart G.C., and Givertz M.M. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 119 (2009) 2225-2232
22. Murali S., Uretsky B.F., Armitage J.M., et al. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 11 (1992) 716-723
23. Tenderich G., Koerner M.M., Stuettgen B., et al. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation. J of Cardiovasc Surg 41 (2000) 215-219
24. Zink M., Gombotz H., Wasler A., Grasser B., Rehak P., and Metzler H.I. Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation. J Heart Lung Transplant 21 (2002) 347-353
25. Balzer D.T., Kort H.W., Day R.W., et al. Inhaled nitric oxide as a preoperative test (INOP Test I): the INOP test study group. Circulation 106 (2002) 176-181
26. Givertz M.M., Hare J.M., Loh E., Gauthier D.F., and Colucci W.S. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 28 (1996) 1775-1780
27. Radovancevic B., Vrtovec B., Thomas C.D., et al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. J Heart Lung Transplant 24 (2005) 690-695
28. Taylor D.O., Edwards L.B., Boucek M.M., et al. Twenty-first annual report of the Registry of the International Society of Heart and Lung Transplantation. J Heart Lung Transplant 26 (2007) 769-781
29. Haddad H., Elabbassi W., Moustafa S., et al. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J 51 (2005) 456-460